


Lila Sciences
Builds AI models joined to automated 'AI Science Factories' that design, run and learn from experiments in life science, chemistry and materials.
Money and evidence
Latest round, Series B (in talks), 2026-06-03: the record then held no research entry for the company. The first research entry is dated 2026-08-28; the highest level so far is 4 (Tested in the physical world).
Rounds and research, on one timeline
- 2026-09-24Research
Level 4 · Tested in the physical world
Lila Sciences' AI-guided lab finds an iridium-free catalyst for green hydrogen, stable for 1,000+ hours
On replayed data, Lila's agent reached the palladium family in 11 material systems and plain active search in 10, against 18 for Bayesian optimisation and for random search; Claude Opus 4.6 choosing alone seldom reached it within 50. The agent's edge in the paper is moving the activity-stability frontier faster, not finding palladium.
- 2026-08-28Research
Level 4 · Tested in the physical world
Lila says its platform designed an in vivo CAR-T mRNA that beat a benchmark in monkeys; its conference abstract and its blog give different figures
The two Lila sources do not agree. Time: three months in the abstract, under six in the blog. Day 14: B cells back to about 50% of baseline in the abstract, depletion maintained in the blog. Benchmark: back to baseline in the abstract, past it in the blog. Neither names the benchmark or gives animal numbers or statistics, so the claim to beat the leading therapy cannot yet be checked.
- 2026-06-03Series BIn talksRound
about $2 billion$8.5B pre · stated by Bloomberg
Not stated
In talks per people familiar; Bloomberg says the round is 'anchored' by CalPERS and NVentures. Lila and CalPERS declined to comment. No close announced by Lila, CalPERS, NVIDIA or a named outlet as of 2026-10-07.
Anchor · CalPERSAnchor · NVentures (NVIDIA) ✓
Reported by Bloomberg · news.bloombergtax.com ↗On the timeline →
- 2025-10-10Series A extensionRound
$115M
For: build more AI Science Factories and open the platform to customers
Automated labCommercial roll-out
Extension to the Series A, bringing it to $350M and total capital raised to $550M (seed $200M plus Series A $350M), per Lila's own close post at lila.ai/news/announcing-the-close-of-our-series-a.
NVentures (NVIDIA) ✓Analog DevicesIQTDauntless Ventures ✓Catalio Capital Management ✓Pennant InvestorsAbundance Membership investors
- 2025-09-15Series ARound
$235M
For: scale AI Science Factories
Automated lab
First close of the Series A; the round later closed at $350M in total.
Co-lead · BraidwellCo-lead · Collective GlobalGeneral Catalyst ✓Flagship Pioneering ✓March CapitalARK Venture FundAlumni VenturesState of Michigan Retirement SystemAltitude Life Science Ventures ✓Common MetalDara HoldingsMathers FoundationModi VenturesNGS SuperADIA (subsidiary)
- 2025-03-10SeedRound
$200M
For: develop the platform and build the first AI Science Factories
Automated labModels and platform
Described as 'committed seed capital' from Flagship and co-investors; the release names no separate lead.
Flagship Pioneering ✓General Catalyst ✓March CapitalARK Venture FundAltitude Life Science Ventures ✓State of Michigan Retirement SystemADIA (subsidiary)Blue Horizon AdvisorsModi Ventures
The investor's own page says · General Catalyst: Seed
Announced by the company · prnewswire.com ↗On the timeline →
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
On the investors' own sites
Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.
- Altitude Life Science VenturesFund IValtitudelsv.com ↗
- Catalio Capital Managementcataliocapital.com ↗
- Dauntless Venturesdauntless.vc ↗
- Flagship Pioneeringflagshippioneering.com ↗
- General CatalystSeedgeneralcatalyst.com ↗
- NVentures (NVIDIA)nvidia.com ↗
Its investors also backed
Other companies on this page whose rounds name the same investor.
- NVentures (NVIDIA)EvolutionaryScale, Generate:Biomedicines, Iambic Therapeutics, Inceptive, Genesis Molecular AI (formerly Genesis Therapeutics), Terray Therapeutics, Periodic Labs, Radical AI, Achira, CuspAI, Orbital Industries, Basecamp Research, Relation Therapeutics, Mirendil, Superluminal Medicines, Ricursive Intelligence, AMI Labs, Recursive Superintelligence, Inherent, Generalist AI, Ineffable Intelligence
- Catalio Capital ManagementIambic Therapeutics, Enveda, BigHat Biosciences, Noetik, Medra, Basecamp Research, Superluminal Medicines
- General CatalystTransfyr, Chai Discovery
- ADIAGenerate:Biomedicines
- Altitude Life Science VenturesGenerate:Biomedicines
- Alumni VenturesIambic Therapeutics
- ARKIambic Therapeutics
- Blue HorizonBasecamp Research
- Flagship PioneeringGenerate:Biomedicines
- March CapitalGenerate:Biomedicines